Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Prepaid Assets (2017 - 2021)

Cogent Biosciences has reported Prepaid Assets over the past 5 years, most recently at $4.6 million for Q3 2021.

  • Quarterly results put Prepaid Assets at $4.6 million for Q3 2021, up 15.52% from a year ago — trailing twelve months through Sep 2021 was $4.6 million (up 15.52% YoY), and the annual figure for FY2020 was $2.7 million, up 133.25%.
  • Prepaid Assets for Q3 2021 was $4.6 million at Cogent Biosciences, up from $3.2 million in the prior quarter.
  • Over the last five years, Prepaid Assets for COGT hit a ceiling of $4.6 million in Q3 2021 and a floor of $513000.0 in Q4 2017.
  • Median Prepaid Assets over the past 5 years was $1.3 million (2019), compared with a mean of $1.8 million.
  • Biggest five-year swings in Prepaid Assets: tumbled 35.63% in 2019 and later surged 228.62% in 2020.
  • Cogent Biosciences' Prepaid Assets stood at $513000.0 in 2017, then surged by 44.25% to $740000.0 in 2018, then soared by 57.7% to $1.2 million in 2019, then skyrocketed by 133.25% to $2.7 million in 2020, then skyrocketed by 69.58% to $4.6 million in 2021.
  • The last three reported values for Prepaid Assets were $4.6 million (Q3 2021), $3.2 million (Q2 2021), and $1.3 million (Q1 2021) per Business Quant data.